Longboard Pharmaceuticals ($LBPH) soared in trading on Monday after announcing that Dutch pharmaceutical company Lundbeck ...

，丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals (LBPH.US)。在这一重磅消息刺激之下，截至发稿，Longboard股价在美股盘前交易中的涨幅超过50%。截至上周美股收盘，Longboard总市值约15亿美元，股价则收于38.90美元，均远低于 Lundbeck发起的收购规模 。

Longboard Pharmaceuticals has displayed a staggering YTD performance of +875.79%, significantly outpacing the S&P 500’s +22.85%. This impressive rise highlights not just the company’s operational ...

Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the ...

Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) to H. Lundbeck A/S for $60.00 per share in cash share is fair to ...

H. Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing ...

Danish pharmaceutical company H. Lundbeck A/S (HLUKY.PK, HLUKF.PK) and Longboard Pharmaceuticals, Inc. (LBPH), announced Monday an ...

(RTTNews) - Shares of Longboard Pharmaceuticals, Inc. (LBPH) were surging more than 50 percent in pre-market on Monday on the news of it being acquired by H. Lundbeck A/S in a transaction valued about ...

Lundbeck agreed to acquire Longboard Pharmaceuticals in a transaction valued at approximately $2.6 billion equity value. Longboard Pharmaceuticals shares jumped 46.8% to $57.13 in the pre-market ...

H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

On Monday, Longboard Pharmaceuticals Inc (LBPH) stock saw a decline, ending the day at $33.35 which represents a decrease of $-2.87 or -7.92% from the prior close of $36.22. The stock opened at $36.16 ...